Metropolitan Life Insurance Company (MetLife)’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,646
| Closed | -$571K | – | 2430 |
|
|
2022
Q1 | $571K | Sell |
6,646
-37,589
| -85% | -$3.09M | 0.02% | 519 |
|
|
2021
Q4 | $3.61M | Sell |
44,235
-1,150
| -3% | -$84K | 0.05% | 298 |
|
|
2021
Q3 | $3.02M | Sell |
45,385
-48,605
| -52% | -$3.45M | 0.04% | 345 |
|
|
2021
Q2 | $6.3M | Buy |
93,990
+47,884
| +104% | +$2.97M | 0.05% | 330 |
|
|
2021
Q1 | $2.4M | Buy |
46,106
+1
| +0% | +$51 | 0.04% | 436 |
|
|
2020
Q4 | $1.84M | Sell |
46,105
-2,631
| -5% | -$84.9K | 0.03% | 516 |
|
|
2020
Q3 | $1.19M | Sell |
48,736
-1,367
| -3% | -$34.9K | 0.02% | 638 |
|
|
2020
Q2 | $907K | Sell |
50,103
-6,979
| -12% | -$138K | 0.02% | 791 |
|
|
2020
Q1 | $822K | Sell |
57,082
-1,179
| -2% | -$33.8K | 0.02% | 781 |
|
|
2019
Q4 | $2.22M | Sell |
58,261
-1,761
| -3% | -$52.7K | 0.04% | 488 |
|
|
2019
Q3 | $1.33M | Buy |
60,022
+9,644
| +19% | +$205K | 0.02% | 705 |
|
|
2019
Q2 | $1.04M | Buy |
50,378
+1,632
| +3% | +$37.6K | 0.02% | 871 |
|
|
2019
Q1 | $1.41M | Sell |
48,746
-539
| -1% | -$13.3K | 0.03% | 683 |
|
|
2018
Q4 | $845K | Buy |
49,285
+676
| +1% | +$16.4K | 0.02% | 896 |
|
|
2018
Q3 | $1.38M | Buy |
48,609
+297
| +0.6% | +$9.81K | 0.02% | 741 |
|
|
2018
Q2 | $1.62M | Buy |
48,312
+2,470
| +5% | +$76.8K | 0.03% | 642 |
|
|
2018
Q1 | $1.11M | Sell |
45,842
-1,231
| -3% | -$24.5K | 0.02% | 855 |
|
|
2017
Q4 | $714K | Sell |
47,073
-82,201
| -64% | -$1.16M | 0.01% | 1063 |
|
|
2017
Q3 | $2.12M | Sell |
129,274
-41
| -0% | -$695 | 0.01% | 924 |
|
|
2017
Q2 | $2.5M | Buy |
129,315
+51,680
| +67% | +$902K | 0.02% | 878 |
|
|
2017
Q1 | $1.38M | Sell |
77,635
-64
| -0.1% | -$1.19K | 0.01% | 1088 |
|
|
2016
Q4 | $1.15M | Sell |
77,699
-395
| -0.5% | -$7.09K | 0.01% | 1223 |
|
|
2016
Q3 | $1.77M | Sell |
78,094
-18,278
| -19% | -$476K | 0.01% | 999 |
|
|
2016
Q2 | $2.66M | Buy |
96,372
+39,914
| +71% | +$1.18M | 0.02% | 832 |
|
|
2016
Q1 | $1.63M | Sell |
56,458
-1,674
| -3% | -$43.5K | 0.01% | 964 |
|
|
2015
Q4 | $1.76M | Sell |
58,132
-237
| -0.4% | -$7.77K | 0.01% | 945 |
|
|
2015
Q3 | $2.15M | Sell |
58,369
-812
| -1% | -$42K | 0.02% | 884 |
|
|
2015
Q2 | $3.42M | Buy |
59,181
+654
| +1% | +$33.4K | 0.02% | 737 |
|
|
2015
Q1 | $2.9M | Sell |
58,527
-607
| -1% | -$28.4K | 0.02% | 759 |
|
|
2014
Q4 | $3M | Sell |
59,134
-187
| -0.3% | -$9.77K | 0.02% | 784 |
|
|
2014
Q3 | $3.52M | Sell |
59,321
-798
| -1% | -$44.5K | 0.03% | 677 |
|
|
2014
Q2 | $2.82M | Sell |
60,119
-2,360
| -4% | -$107K | 0.02% | 834 |
|
|
2014
Q1 | $2.67M | Sell |
62,479
-2,680
| -4% | -$118K | 0.02% | 838 |
|
|
2013
Q4 | $2.74M | Sell |
65,159
-3,270
| -5% | -$142K | 0.02% | 804 |
|
|
2013
Q3 | $2.82M | Sell |
68,429
-1,683
| -2% | -$70.4K | 0.02% | 754 |
|
|
2013
Q2 | $3.23M | Buy |
+70,112
| New | +$3.14M | 0.03% | 650 |
|
Other funds holding THC
GCM
CCA
Metropolitan Life Insurance Company (MetLife)'s THC Position: Q2 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 6,646 shares — an estimated $571K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in THC in Q2 2013 and held it in 36 quarters. The position peaked at $6.3M in Q2 2021. 371 funds tracked by Wall St. Rank hold THC as of Q2 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 6,646 Tenet Healthcare shares in Q2 2022, an estimated $571K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Tenet Healthcare in Q2 2013 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Tenet Healthcare position peaked at $6.3M in Q2 2021.
- 371 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.